TADALAFIL CITRATE

Tadalafil Citrate [Cas No. 171596-29-5] is a pharma grade phosphodiesterase type 5 [PDE5] inhibitor API which has potency in treating erectile dysfunction [ED] and pulmonary arterial hypertension [PAH]. Tadalafil Citrate has pyrazinopyridoindole and benzodioxol derivative that enhances nitric acid [NO] mediated vasodilation by inhibiting cGMP, resulting in smooth muscle relaxation and increase blood flow.  Tadalafil Citrate is well known for its long duration action for up to 36 hours and possess dual benefits in urological health and cardiopulmonary support. Tadalafil Citrate is globally marketed by brand name Cialis [for ED] and Adcirca [for PAH] and usually targets vascular performance, sexual wellness and pulmonary function.

Chemox Pharma is the largest manufacturer of Tadalafil Citrate API in IP/BP/EP/USP grade and ensures high-purity products with highest level of compliance. Chemox Pharma offers global regulatory supports and reliable supply chain solutions – establishing us as a trusted partner by pharmaceutical companies over 90 countries, reflecting global footprints and reputation.